2023年6月最新SCI影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER LETTERS CANCER LETT （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.0
56人评分
我要评分
声誉 9.9 影响力 8.2 速度 9.3 | |||||||||||||||||||||
| 期刊ISSN | 0304-3835 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| E-ISSN | 1872-7980 | |||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 9.7 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2023年6月16日：9.614 | |||||||||||||||||||||
| 2022-2023自引率 | 2.10%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 8.9 | |||||||||||||||||||||
| h-index | 161 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 | CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease. | |||||||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/506050/description#description | |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/CANLET | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CANCER LETTERS的语言要求，还能让CANCER LETTERS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CANCER LETTERS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000 | |||||||||||||||||||||
| 出版商 | Elsevier Ireland Ltd | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Biweekly | |||||||||||||||||||||
| 出版年份 | 1975 | |||||||||||||||||||||
| 年文章数 | 314点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 18.78% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 95.22% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-3835%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2.7个月 来源Elsevier官网： 平均3.3周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约52.27% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CANCER LETTERS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均8.3周 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Patient-derived organoids in translational oncology and drug screening Author: Yang, Ruixin; Yu, Yingyan Journal: CANCER LETTERS. 2023; Vol. 562, Issue , pp. -. DOI: 10.1016/j.canlet.2023.216180 PubMed DOI |
| 2. | PIWI-interacting RNAs: Critical roles and therapeutic targets in cancer Author: Zhou, Jialin; Xie, Han; Liu, Jun; Huang, Ruixiang; Xiang, Yufei; Tian, Dasheng; Bian, Erbao Journal: CANCER LETTERS. 2023; Vol. 562, Issue , pp. -. DOI: 10.1016/j.canlet.2023.216189 PubMed DOI |
| 3. | Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions Author: Zhang, Chenyue; Zhang, Chenxing; Wang, Haiyong Journal: CANCER LETTERS. 2023; Vol. 562, Issue , pp. -. DOI: 10.1016/j.canlet.2023.216182 PubMed DOI |
| 4. | Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers Author: Shi, Fukang; Huang, Xing; Hong, Zhengtao; Lu, Na; Huang, Xin; Liu, Lingyue; Liang, Tingbo; Bai, Xueli Journal: CANCER LETTERS. 2023; Vol. 562, Issue , pp. -. DOI: 10.1016/j.canlet.2023.216167 PubMed DOI |
| 5. | Ultrasound-excited temozolomide sonosensitization induces necroptosis in glioblastoma Author: Wang, Fanchen; Xu, Lixia; Wen, Binli; Song, Sirong; Zhou, Yan; Wu, Haiyang; Wu, Qiaoli; Wang, Yinsong; Tong, Xiaoguang; Yan, Hua Journal: CANCER LETTERS. 2023; Vol. 554, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216033 PubMed DOI |
| 6. | Gut microbiota and colorectal cancer metastasis Author: Zheng, Zongmei; Hou, Xinxin; Bian, Zhaoxiang; Jia, Wei; Zhao, Ling Journal: CANCER LETTERS. 2023; Vol. 555, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216039 PubMed DOI |
| 7. | SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity Author: Zheng, Wenfang; Yang, Zhiyi; Song, Ping; Sun, Yingchao; Liu, Pan; Yue, Lei; Lv, Kaiqi; Wang, Xinjie; Shen, Yuqin; Si, Jianmin; Zhang, Xue; Ke, Yuehai; Cheng, Hongqiang; Hu, Weiling Journal: CANCER LETTERS. 2023; Vol. 555, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216029 PubMed DOI |
| 8. | Immune checkpoint inhibitor resistance in hepatocellular carcinoma Author: Wang, Zhijie; Wang, Yichuan; Gao, Peng; Ding, Jin Journal: CANCER LETTERS. 2023; Vol. 555, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216038 PubMed DOI |
| 9. | 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death Author: Sun, Zhuoran; Zhao, Mingyi; Wang, Weibi; Hong, Lanhui; Wu, Zhongguang; Luo, Guang; Lu, Siyao; Tang, Yueyue; Li, Jiehan; Wang, Jiangang; Zhang, Yingjie; Zhang, Lingling Journal: CANCER LETTERS. 2023; Vol. 554, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216032 PubMed DOI |
| 10. | Sex steroid axes in determining male predominance in hepatocellular carcinoma Author: Zhang, Lei; Wu, JinFeng; Wu, QiuMei; Zhang, XiangJuan; Lin, ShuaiCai; Ran, WanLi; Zhu, Li; Tang, ChengYan; Wang, Xing Journal: CANCER LETTERS. 2023; Vol. 555, Issue , pp. -. DOI: 10.1016/j.canlet.2022.216037 PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共18条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
